Karyopharm Therapeutics | KPTI - Market Capitalization


Karyopharm Therapeutics reported $233.6M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Abbott USD 158.05B 20.36B Jun/2026
Amgen USD 209.65B 14.21B Aug/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
BioCryst Pharmaceuticals USD 1.9B 643M Aug/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Eli Lilly USD 1.11T 18.32B Aug/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Incyte USD 26.84B 4.19B Aug/2026
J&J USD 611.36B 32.21B Jun/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
MacroGenics USD 184M 82M Mar/2026
Merck USD 324.18B 6.81B Aug/2026
Nektar Therapeutics USD 12.98B 10.86B Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Novartis USD 288.26B 25.18B Mar/2026
Pfizer USD 153.17B 14.73B Aug/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Takeda JPY 8.2T 809.7B Jun/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
TG Therapeutics USD 7.63B 778M Aug/2026
Ultragenyx Pharmaceutical USD 2.12B 1.16B Aug/2026
Xencor USD 1.21B 19M Aug/2026